Zobrazeno 1 - 8
of 8
pro vyhledávání: '"TrypanoGEN+ Research group"'
Autor:
Peter Nambala, Julius Mulindwa, Harry Noyes, Vincent Pius Alibu, Barbara Nerima, Joyce Namulondo, Oscar Nyangiri, Enock Matovu, Annette MacLeod, Janelisa Musaya, TrypanoGEN+ Research Group as Members of the H3Africa Consortium
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 12, p e0011803 (2023)
T. b. rhodesiense is the causative agent of Rhodesian human African trypanosomiasis (r-HAT) in Malawi. Clinical presentation of r-HAT in Malawi varies between foci and differs from East African HAT clinical phenotypes. The purpose of this study was t
Externí odkaz:
https://doaj.org/article/8a1396f2b3614bf88d218de030be6917
Autor:
Oscar Asanya Nyangiri, Julius Mulindwa, Joyce Namulondo, Anna Kitibwa, Jacent Nassuuna, Alison Elliott, Magambo Phillip Kimuda, Alex Boobo, Barbara Nerima, Moses Adriko, Nathan J Dunton, Gaganjit Kaur Madhan, Mark Kristiansen, Miriam Casacuberta-Partal, Harry Noyes, Enock Matovu, TrypanoGEN+ Research group of the H3Africa consortium
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 11, p e0011796 (2023)
BackgroundIndividuals genetically susceptible to high schistosomiasis worm burden may contribute disproportionately to transmission and could be prioritized for control. Identifying genes involved may guide development of therapy.Methodology/principa
Externí odkaz:
https://doaj.org/article/2ab6d4fb87d4440c8b600bae9a0b301a
Autor:
Joyce Namulondo, Oscar Asanya Nyangiri, Magambo Phillip Kimuda, Peter Nambala, Jacent Nassuuna, Moses Egesa, Barbara Nerima, Savino Biryomumaisho, Claire Mack Mugasa, Immaculate Nabukenya, Drago Kato, Alison Elliott, Harry Noyes, Robert Tweyongyere, Enock Matovu, Julius Mulindwa, TrypanoGEN+ research group of the H3Africa consortium
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 11, p e0011455 (2023)
Over 290 million people are infected by schistosomes worldwide. Schistosomiasis control efforts focus on mass drug treatment with praziquantel (PZQ), a drug that kills the adult worm of all Schistosoma species. Nonetheless, re-infections have continu
Externí odkaz:
https://doaj.org/article/852fe9f9296a4407b9141ae6ed2d0c3b
Autor:
Estelle Mezajou Mewamba, Arnol Auvaker Zebaze Tiofack, Cyrille Nguemnang Kamdem, Esthelline Yangea Tchounkeu, Rostand Joël Atiokeng Tatang, Loic Edmond Tekeu Mengoue, Mureille Carole Tchami Mbagnia, Flobert Njiokou, Miriam Casacuberta-Partal, Hilaire Macaire Womeni, Gustave Simo, TrypanoGEN+ research group of the H3Africa consortium
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 10, p e0010852 (2022)
BackgroundSchistosomiasis control relies mainly on mass drug administration of Praziquantel (PZQ) to school aged children (SAC). Although precision mapping has recently guided decision making, the sub-districts and the epidemiological differences exi
Externí odkaz:
https://doaj.org/article/8d3fb817d11f4666bda1624980ade73e
Autor:
Julius Mulindwa, Joyce Namulondo, Anna Kitibwa, Jacent Nassuuna, Oscar Asanya Nyangiri, Magambo Phillip Kimuda, Alex Boobo, Barbara Nerima, Fred Busingye, Rowel Candia, Annet Namukuta, Ronald Ssenyonga, Noah Ukumu, Paul Ajal, Moses Adriko, Harry Noyes, Claudia J de Dood, Paul L A M Corstjens, Govert J van Dam, Alison M Elliott, Enock Matovu, TrypanoGEN+ Research group
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 7, p e0010570 (2022)
BackgroundKnowing the prevalence of schistosomiasis is key to informing programmes to control and eliminate the disease as a public health problem. It is also important to understand the impact of infection on child growth and development in order to
Externí odkaz:
https://doaj.org/article/c9d0c1f44ec946ffb7680ccffd5f1cbb
Autor:
Nyangiri, Oscar A, Edwige, Sokouri A, Koffi, Mathurin, Mewamba, Estelle, Simo, Gustave, Namulondo, Joyce, Mulindwa, Julius, Nassuuna, Jacent, Elliott, Alison, Karume, Kévin, Mumba, Dieudonne, Corstjens, PLAM, Casacuberta-Partal, M, van Dam, GJ, Bucheton, Bruno, Noyes, Harry, Matovu, Enock, TrypanoGEN+ Research Group of the H3Africa Consortium
Background: Approximately 25% of the risk of Schistosoma mansoni is associated with host genetic variation. We will test 24 candidate genes, mainly in the T h2 and T h17 pathways, for association with S. mansoni infection intensity in four African co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d133259277d682b197ccca08c79f375a
Autor:
Edwige A. Sokouri, Bernardin Ahouty Ahouty, Martial N’Djetchi, Innocent A. Abé, Ble Gbacla Flora Dominique Yao, Thomas Konan Konan, Annette MacLeod, Harry Noyes, Oscar Nyangiri, Enock Matovu, Mathurin Koffi, the TrypanoGEN+ Research Group of the H3Africa Consortium
Publikováno v:
Parasites & Vectors, Vol 17, Iss 1, Pp 1-12 (2024)
A bstract Background Intestinal schistosomiasis remains a worrying health problem, particularly in western Côte d'Ivoire, despite control efforts. It is therefore necessary to understand all the factors involved in the development of the disease, in
Externí odkaz:
https://doaj.org/article/36af9fdfbbcf41f3967fbbcf7f78f4fd
Autor:
Adamson WE; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom; Wellcome Centre for Integrative Parasitology, University of Glasgow, United Kingdom; TrypanoGEN+ Research Group, Uganda, Member of the H3Africa Consortium, South Africa. Electronic address: Walt.Adamson@glasgow.ac.uk., Noyes H; TrypanoGEN+ Research Group, Uganda, Member of the H3Africa Consortium, South Africa; Centre for Genomic Research, University of Liverpool, United Kingdom., Johnson P; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom., Cooper A; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom; Wellcome Centre for Integrative Parasitology, University of Glasgow, United Kingdom., Monckton DG; School of Molecular Biosciences, University of Glasgow, United Kingdom., Ogunsola J; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom; Wellcome Centre for Integrative Parasitology, University of Glasgow, United Kingdom., Beckett-Hill G; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom., Sullivan M; School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom., Mark P; School of Cardiovascular and Metabolic Health, University of Glasgow, United Kingdom., Parekh RS; Women's College Hospital, Hospital for Sick Children and University of Toronto, Canada., MacLeod A; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, United Kingdom; Wellcome Centre for Integrative Parasitology, University of Glasgow, United Kingdom; TrypanoGEN+ Research Group, Uganda, Member of the H3Africa Consortium, South Africa. Electronic address: Annette.Macleod@glasgow.ac.uk.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Mar; Vol. 101, pp. 105000. Date of Electronic Publication: 2024 Feb 14.